New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ...

A national study of more than 20,000 men with localized prostate cancer found that surgery was linked to higher rates of urinary incontinence and erectile dysfunction, while radiation therapy was ...

Briganti and colleagues concluded that, together with the main PROTEUS study, the substudy supports 1-year perioperative apalutamide plus ADT as a treatment option for patients with high-risk ...

There is a question I am often asked by patients diagnosed with prostate cancer."In the end, which is better, surgery or ...

Results show excellent early functional recovery in clinically complex patients with advanced prostate cancer ... Read More ...

What matters in prostate cancer treatment is not simply removing the cancer. How much urinary and sexual function can be ...

A national study of more than 20,000 men with prostate cancer compared long-term outcomes after radiation therapy or surgical removal of the prostate, with follow-up of up to 20 years. Men who ...

Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule ...

Prostate cancer upgrading was independently associated with elevated PSA density and perineural invasion in a retrospective ...

Salvage radiation after surgery: If PSA rises after surgery, radiation to the area where the prostate was can still be ...

Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to radiation and active surveillance. Because prostate cancer grows slowly, patients ...

Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given ...